Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of chemotherapy in older versus non-older patients with advanced gastric cancer: A real-world data, non-inferiority analysis.
Visa L, Jiménez-Fonseca P, Martínez EA, Hernández R, Custodio A, Garrido M, Viudez A, Buxo E, Echavarria I, Cano JM, Macias I, Mangas M, de Castro EM, García T, Manceñido FÁ, Montes AF, Azkarate A, Longo F, Serrano AD, López C, Hurtado A, Cerdá P, Serrano R, Gil-Negrete A, Carnicero AM, Pimentel P, Ramchandani A, Carmona-Bayonas A; AGAMENON Study Group. Visa L, et al. Among authors: cerda p. J Geriatr Oncol. 2018 May;9(3):254-264. doi: 10.1016/j.jgo.2017.11.008. Epub 2017 Dec 11. J Geriatr Oncol. 2018. PMID: 29242093
Prognostic significance of performing universal HER2 testing in cases of advanced gastric cancer.
Jiménez-Fonseca P, Carmona-Bayonas A, Sánchez Lorenzo ML, Plazas JG, Custodio A, Hernández R, Garrido M, García T, Echavarría I, Cano JM, Rodríguez Palomo A, Mangas M, Macías Declara I, Ramchandani A, Visa L, Viudez A, Buxó E, Díaz-Serrano A, López C, Azkarate A, Longo F, Castañón E, Sánchez Bayona R, Pimentel P, Limón ML, Cerdá P, Álvarez Llosa R, Serrano R, Lobera MPF, Alsina M, Hurtado Nuño A, Gómez-Martin C. Jiménez-Fonseca P, et al. Among authors: cerda p. Gastric Cancer. 2017 May;20(3):465-474. doi: 10.1007/s10120-016-0639-8. Epub 2016 Sep 6. Gastric Cancer. 2017. PMID: 27599830 Free article.
Anthracycline-based triplets do not improve the efficacy of platinum-fluoropyrimidine doublets in first-line treatment of advanced gastric cancer: real-world data from the AGAMEMON National Cancer Registry.
Carmona-Bayonas A, Jiménez-Fonseca P, Custodio A, Sánchez Cánovas M, Hernández R, Pericay C, Echavarria I, Lacalle A, Visa L, Rodríguez Palomo A, Mangas M, Cano JM, Buxo E, Álvarez-Manceñido F, García T, Lorenzo JE, Ferrer-Cardona M, Viudez A, Azkarate A, Ramchandani A, Arias D, Longo F, López C, Sánchez Bayona R, Limón ML, Díaz-Serrano A, Fernández Montes A, Sala P, Cerdá P, Rivera F, Gallego J; AGAMENON study group. Carmona-Bayonas A, et al. Among authors: cerda p. Gastric Cancer. 2018 Jan;21(1):96-105. doi: 10.1007/s10120-017-0718-5. Epub 2017 Apr 9. Gastric Cancer. 2018. PMID: 28393278 Free article.
Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry.
Jiménez Fonseca P, Carmona-Bayonas A, Hernández R, Custodio A, Cano JM, Lacalle A, Echavarria I, Macias I, Mangas M, Visa L, Buxo E, Álvarez Manceñido F, Viudez A, Pericay C, Azkarate A, Ramchandani A, López C, Martinez de Castro E, Fernández Montes A, Longo F, Sánchez Bayona R, Limón ML, Diaz-Serrano A, Martin Carnicero A, Arias D, Cerdà P, Rivera F, Vieitez JM, Sánchez Cánovas M, Garrido M, Gallego J. Jiménez Fonseca P, et al. Among authors: cerda p. Br J Cancer. 2017 Sep 5;117(6):775-782. doi: 10.1038/bjc.2017.245. Epub 2017 Aug 1. Br J Cancer. 2017. PMID: 28765618 Free PMC article.
Surgery for metastases for esophageal-gastric cancer in the real world: Data from the AGAMENON national registry.
Carmona-Bayonas A, Jiménez-Fonseca P, Echavarria I, Sánchez Cánovas M, Aguado G, Gallego J, Custodio A, Hernández R, Viudez A, Cano JM, Martínez de Castro E, Macías I, Martín Carnicero A, Garrido M, Mangas M, Álvarez Manceñido F, Visa L, Azkarate A, Ramchandani A, Fernández Montes A, Longo F, Sánchez A, Pimentel P, Limón ML, Arias D, Cacho Lavin D, Sánchez Bayona R, Cerdá P, García Alfonso P; AGAMENON Study Group. Carmona-Bayonas A, et al. Among authors: cerda p. Eur J Surg Oncol. 2018 Aug;44(8):1191-1198. doi: 10.1016/j.ejso.2018.03.019. Epub 2018 Mar 31. Eur J Surg Oncol. 2018. PMID: 29685755
Optimal duration of first-line chemotherapy for advanced gastric cancer: data from the AGAMENON registry.
Viúdez A, Carmona-Bayonas A, Gallego J, Lacalle A, Hernández R, Cano JM, Macías I, Custodio A, Martínez de Castro E, Sánchez A, Iglesia L, Reguera P, Visa L, Azkarate A, Sánchez-Cánovas M, Mangas M, Limón ML, Martínez-Torrón A, Asensio E, Ramchandani A, Martín-Carnicero A, Hurtado A, Cerdà P, Garrido M, Sánchez-Bayonas R, Serrano R, Jiménez-Fonseca P; AGAMENON Study Group. Viúdez A, et al. Among authors: cerda p. Clin Transl Oncol. 2020 May;22(5):734-750. doi: 10.1007/s12094-019-02183-y. Epub 2019 Aug 5. Clin Transl Oncol. 2020. PMID: 31385226
Multistate Models: Accurate and Dynamic Methods to Improve Predictions of Thrombotic Risk in Patients with Cancer.
Carmona-Bayonas A, Jimenez-Fonseca P, Garrido M, Custodio A, Hernandez R, Lacalle A, Cano JM, Aguado G, Martínez de Castro E, Alvarez Manceñido F, Macias I, Visa L, Martín Richard M, Mangas M, Sánchez Cánovas M, Longo F, Iglesias Rey L, Martínez Lago N, Martín Carnicero A, Sánchez A, Azkárate A, Limón ML, Hernández Pérez C, Ramchandani A, Pimentel P, Cerdá P, Serrano R, Gil-Negrete A, Marín M, Hurtado A, Sánchez Bayona R, Gallego J. Carmona-Bayonas A, et al. Among authors: cerda p. Thromb Haemost. 2019 Nov;119(11):1849-1859. doi: 10.1055/s-0039-1694012. Epub 2019 Aug 28. Thromb Haemost. 2019. PMID: 31461750
External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit?
Jimenez-Fonseca P, Carmona-Bayonas A, Martínez de Castro E, Custodio A, Pericay Pijaume C, Hernandez R, Aguado G, Castro Unanua N, Cano JM, López F, Garrido M, Fernández Montes A, Visa L, Sánchez Cánovas M, Limón ML, Martínez Lago N, Pimentel P, Hurtado A, Azkárate A, Longo F, Diez M, Arias-Martinez A, Sauri T, Martín Carnicero A, Mangas M, Martín Richard M, Granja M, Ramchandani A, Hernández Pérez C, Cerdá P, Gil-Negrete A, Calvo M, Vidal Tocino R, Gallego J. Jimenez-Fonseca P, et al. Among authors: cerda p. Gastric Cancer. 2021 Mar;24(2):445-456. doi: 10.1007/s10120-020-01116-x. Epub 2020 Sep 24. Gastric Cancer. 2021. PMID: 32970266 Free PMC article.
Real-life use of ramucirumab in gastric cancer in Spain: the RAMIS study.
Longo F, Jorge M, Yaya R, Montes AF, Lago NM, Brozos E, Aparicio J, Quintero G, Ceballos E, Buxó E, Lopez AM, Pellón ML, Molina R, Diaz-Paniagua L, Cerdà P, Leiva PL, Carnicero AM, Cousillas A, Paris L, García-Paredes B, Romero C, Ortega M, Molero A, la Torre S, Jen MH, Díaz-Cerezo S. Longo F, et al. Among authors: cerda p. Future Oncol. 2021 May;17(14):1777-1791. doi: 10.2217/fon-2020-1216. Epub 2021 Feb 16. Future Oncol. 2021. PMID: 33590772 Free article.
Does HER2 status influence in the benefit of ramucirumab and paclitaxel as second line treatment of advanced gastro-esophageal adenocarcinoma? Data from the AGAMENON-SEOM registry.
Valcarcel S, Gallego J, Jimenez-Fonseca P, Diez M, de Castro EM, Hernandez R, Arrazubi V, Custodio A, Cano JM, Montes AF, Macias I, Visa L, Calvo A, Tocino RV, Lago NM, Limón ML, Granja M, Gil M, Pimentel P, Macia-Rivas L, Pérez CH, Mangas M, Carnicero AM, Cerdà P, Gonzalez LG, Navalon FG, Rambla MDM, Richard MM, Carmona-Bayonas A. Valcarcel S, et al. Among authors: cerda p. J Cancer Res Clin Oncol. 2023 Jul;149(7):4077-4089. doi: 10.1007/s00432-022-04294-6. Epub 2022 Aug 30. J Cancer Res Clin Oncol. 2023. PMID: 36042046
70 results